Showing results (21-30 of 529) with videos related to
Sort By:
Pageof 53
Cancer|July 15, 1994
Prostate specific antigen doubling time and disease relapse after radiotherapy for prostate cancerA Pollack, G K Zagars, V S KavadiInternational Journal of Radiation Oncology, Biology, Physics|January 1, 1995
Influence of radiotherapy on node-positive prostate cancer treated with androgen ablationM E Sands, A Pollack, G K ZagarsInternational Journal of Radiation Oncology, Biology, Physics|September 1, 1996
Liposarcoma: outcome and prognostic factors following conservation surgery and radiation therapyG K Zagars, M S Goswitz, A PollackInternational Journal of Radiation Oncology, Biology, Physics|December 30, 1998
Radiation therapy in the management of desmoid tumorsM T Ballo, G K Zagars, A PollackInternational Journal of Radiation Oncology, Biology, Physics|May 1, 1997
Prostate-specific antigen cancer volume: a significant prognostic factor in prostate cancer patients at intermediate risk of failing radiotherapyS P Lankford, A Pollack, G K ZagarsUrology|June 3, 1998
Late effects after radiotherapy for prostate cancer in a randomized dose-response study: results of a self-assessment questionnaireL N Nguyen, A Pollack, G K ZagarsUrology|March 1, 1997
Serum testosterone--a significant determinant of metastatic relapse for irradiated localized prostate cancerG K Zagars, A Pollack, A C von EschenbachUrology|August 8, 2001
Addition of radiation therapy to androgen ablation improves outcome for subclinically node-positive prostate cancerG K Zagars, A Pollack, A C von EschenbachInternational Journal of Radiation Oncology, Biology, Physics|August 30, 1995
Prostate cancer and radiation therapy--the message conveyed by serum prostate-specific antigenG K Zagars, A Pollack, A C von EschenbachCancer|August 15, 1997
Management of unfavorable locoregional prostate carcinoma with radiation and androgen ablationG K Zagars, A Pollack, A C von EschenbachPageof 53